Parallel Advisors, LLC Alkermes Plc. Transaction History

Parallel Advisors, LLC

$4.87 Billion
Q2 2025

A detailed history of Parallel Advisors, LLC transactions in Alkermes Plc. stock. As of the latest transaction made, Parallel Advisors, LLC holds 282 shares of ALKS stock, worth $7,481. This represents 0.0% of its overall portfolio holdings.

Number of Shares

282

Previous 354 20.34%

Holding current value

$7,481

Previous $11,000 27.27%

% of portfolio

0.0%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 07, 2025	SELL	$26.59 - $32.65 $1,914 - $2,350	-72 Reduced 20.34%	282 $8,000
Q1 2025 Apr 07, 2025	SELL	$28.08 - $36.0 $561 - $720	-20 Reduced 5.35%	354 $11,000
Q4 2024 Feb 10, 2025	SELL	$25.7 - $31.46 $10,228 - $12,521	-398 Reduced 51.55%	374 $10,000
Q3 2024 Nov 13, 2024	BUY	$23.01 - $28.55 $11,620 - $14,417	505 Added 189.14%	772 $21,000
Q2 2024 Aug 08, 2024	SELL	$23.21 - $27.24 $1,415 - $1,661	-61 Reduced 18.6%	267 $6,000
Q1 2024 May 06, 2024	BUY	$26.4 - $32.56 $5,438 - $6,707	206 Added 168.85%	328 $8,000
Q4 2023 Feb 09, 2024	SELL	$23.37 - $28.68 $10,609 - $13,020	-454 Reduced 78.82%	122 $3,000
Q3 2023 May 20, 2024	BUY	$27.17 - $31.97 $9,074 - $10,677	334 Added 138.02%	576 $16,000
Q3 2023 Nov 13, 2023	BUY	$27.17 - $31.97 $9,074 - $10,677	334 Added 138.02%	576 $16,000
Q2 2023 May 20, 2024	BUY	$28.34 - $33.63 $4,024 - $4,775	142 Added 142.0%	242 $7,000
Q2 2023 Aug 04, 2023	BUY	$28.34 - $33.63 $4,024 - $4,775	142 Added 142.0%	242 $7,000
Q1 2023 May 20, 2024	SELL	$25.31 - $29.02 $5,770 - $6,616	-228 Reduced 69.51%	100 $2,000
Q1 2023 Apr 25, 2023	BUY	$25.31 - $29.02 $354 - $406	14 Added 16.28%	100 $2,000
Q4 2022 Feb 03, 2023	SELL	$21.94 - $26.24 $1,711 - $2,046	-78 Reduced 47.56%	86 $2,000
Q3 2022 Nov 10, 2022	BUY	$22.0 - $31.87 $1,562 - $2,262	71 Added 76.34%	164 $4,000
Q2 2022 Aug 01, 2022	SELL	$26.4 - $30.54 $1,056 - $1,221	-40 Reduced 30.08%	93 $3,000
Q1 2022 Apr 28, 2022	BUY	$23.07 - $27.99 $1,430 - $1,735	62 Added 87.32%	133 $4,000
Q4 2021 Jan 20, 2022	SELL	$21.47 - $32.08 $214 - $320	-10 Reduced 12.35%	71 $2,000
Q3 2021 Nov 02, 2021	BUY	$23.37 - $32.13 $1,565 - $2,152	67 Added 478.57%	81 $2,000
Q3 2020 Oct 27, 2020	SELL	$16.16 - $20.66 $1,001 - $1,280	-62 Reduced 81.58%	14 $0
Q2 2020 Jul 16, 2020	SELL	$13.31 - $19.41 $53 - $77	-4 Reduced 5.0%	76 $1,000
Q1 2020 Apr 27, 2020	BUY	$13.06 - $21.24 $1,044 - $1,699	80 New	80 $1,000
Q4 2018 Feb 05, 2019	SELL	$27.94 - $44.61 $502 - $802	-18 Closed	0 $0
Q2 2018 Jul 30, 2018	SELL	$40.56 - $51.36 $5,840 - $7,395	-144 Reduced 88.89%	18 $0
Q1 2018 May 08, 2018	BUY	$53.61 - $67.26 $1,876 - $2,354	35 Added 27.56%	162 $9,000
Q3 2017 Nov 15, 2017	BUY	$49.16 - $54.45 $6,243 - $6,915	127 New	127 $6,000
Q3 2017 Nov 14, 2017	SELL	$49.16 - $54.45 $6,341 - $7,024	-129 Closed	0 $0
Q2 2017 Aug 07, 2017	BUY	N/A	129	129 $7,000

Others Institutions Holding ALKS

# of Institutions

407

Shares Held

177M

Call Options Held

229K

Put Options Held

436K

View Full List

About Alkermes plc.

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.36B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

More about ALKS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parallel Advisors, LLC with notifications on news.

Account

Parallel Advisors, LLC Alkermes Plc. Transaction History